🌍 Symposium 4 - Emerging Threats & Novel Solutions Explore new frontiers in #infection control and #vaccines with Andrew Stewardson and Christopher Blyth. Innovation shaping tomorrow’s #health. 👉 Register now: antimicrobials.com.au #Antimicrobials2026 #AMR #IDsky #Medsky #clinmicrosky

Hardly any National Action Plans to address antimicrobial resistance include reducing antibiotic use as an explicit goal 🤯 Report shows only 3 countries had a significant reduction in sales after implementing their NAPs: Jordan, Sth Africa & Indonesia 👏👏 #AMR #NAP doi.org/10.1017/ice....

‘Pharma companies make money on a new drug by selling a lot or charging a lot - but with antimicrobials neither is possible.’ - Andrew Bowskill #AAMRNet. Delinking funding from use is the only way to stimulate investment in new antimicrobials #MTPConnect #AMR #antimicrobials @drewabow.bsky.social

Surveillance of antimicrobial use and resistance ‘in isolation is like counting raindrops in a thunderstorm’ - we need more investment in innovation and prevention of AMR. Dr Richard Alm Speaking in Adelaide #MTPConnect #AAMRNet #AMR #PublicHealth #antimicrobials @carb-x.bsky.social

Study highlights higher risk of multidrug-resistant pathogens in cancer patients: analysis of US data compared cancer outpatient cohort with non-cancer patients. eg. 2-3x higher incidence of carbopenem-resistant P.aeruginosa #AMR #AMS www.thelancet.com/journals/lan... ‪@thelancetoncol.bsky.social‬

Tebipenem - a new oral carbapenem for complicated UTIs - efficacy data is good 😀 Marketing now the challenge - how to make it profitable for pharma but prevent overuse? 🤔 De-linked funding model needed! #tebipenem #PIVOT-PO #antibiotic #de-linked #AMR #AMS www.globenewswire.com/news-release...

Topical use of last-line antibiotics during surgery largely undocumented - potential focus for stewardship and improved governance. Australian surveillance data illustrates rifampicin use not uncommon. doi.org/10.1017/ash....

To celebrate #IDPharmacistsDay look out for the videos from AdPha.au pharmacists showcasing their contributions to Innovations in Infectious Diseases @adphaau.bsky.social @nadinehillock.bsky.social @sonkoning.bsky.social @leggwamy.bsky.social @sidpharm.bsky.social

Analysis of over 208K Salmonella genomes find that #AMR varies by region, source, and serovar, with increases linked to poultry and environment. Antibiotic use, agriculture, and climate drive AMR, offering insights into global spread and evolution. #OneHealth www.nature.com/articles/s41...

This large multi-center study shows cancer patients are infected with #AMR bacteria at 1.2 to 3 times higher rates due to frequent hospital visits and antibiotic use. This highlights the need for better antibiotic #stewardship and surveillance in these patients. www.thelancet.com/journals/lan...

🧪 Antibiotics in our rivers: a global problem A new study has found that 8,500 tonnes of antibiotics from human use end up in rivers every year. In 6 million km of rivers, levels are high enough to harm ecosystems or promote resistance. 🔗 doi.org/10.1093/pnas... #SciComm #WaterQuality #AMR

Interesting webinar coming up on antimicrobial clinical trials conducted after marketing #antimicrobial #AMR #ID @steventong.bsky.social #PatrickHarris @gardp.bsky.social register.gotowebinar.com/register/755...

Sprinkles and washes ... the true extent of topical rifampicin use during surgery is unclear due to lack of documentation - a huge opportunity for stewardship and better governance bit.ly/42nFmQT Thanks to my co-authors Matt Rawlins and @edraby.bsky.social #AMS #off-label #rifampicin #AMR #NAUSP

Price of pretomanid to drop by 25% to increase accessibility for patients with TB. Great example of how global public-private partnerships can increase access to antimicrobials while maintaining economic viability for manufacturing #TB #publichealth #antimicrobials www.stoptb.org/news/global-...

Great comprehensive summary on the safe & effective use of vancomycin in the Australian Prescriber australianprescriber.tg.org.au/articles/saf... Congrats to the authors! @leggwamy.bsky.social @tonylai.bsky.social @feliciadevchand.bsky.social @amandagwee.bsky.social Indy Sandaradura #vancomycin #AMS

Large study ties early-life antibiotic exposure to higher risk of asthma, allergies, other conditions The authors of the observational study say the findings highlight the need for more judicious antibiotic prescribing in children under age 2. www.cidrap.umn.edu/a...

Deaths due to antimicrobial resistance are increasing, especially in children in South East Asia and Africa. New study estimates 3 million kids died in 2022 globally due to AMR @cidrap.bsky.social #AMR #publichealth #mortality #antibioticresistance www.cidrap.umn.edu/antimicrobia...

Go where the money is? No go where the AMR is. Asia remains the epicenter of antimicrobial resistance, yet is underrepresented in clinical trials. David Paterson’s keynote at #ESCMIDGlobal 2025 @escmid.bsky.social underscores the urgency the need for urgent action 🙌 #AMR #ESCMIDGlobal2025

The most anticipated RCT in ID 🔥SNAP RCT🔥The largest RCT 2 date in SA bactermia N:1341 Cefazolin Vs ASPs ((flu)cloxacillin) for MSSA bacteremia Cefazolin is non-inferior (90d mortality)& less AKI than ASPs A practice-changer RCT that must change the guidelines #ESCMIDGlobal #IDSky

@steventong.bsky.social presents the results of the PSSA domain of the SNAP 🫰 trial - the worlds largest trial of staph aureus bacteremia - at #ESCMID2025 fluclox resulted in higher mortality and more AKI compared to penicillin for PSSA

JAMA review of Staph aureus bacteraemia. Empiric treatment should include MRSA cover in areas with rates >5% or in patients with risk MRSA risk factors #SAB @jama.com @steventong.bsky.social

Guide to buying sustainable chocolate this Easter 🐰🐇 #GoodEgg versus #BadEgg @theconversation.com #antislavery #climatesmart #sustainability #genderequity theconversation.com/heres-who-to...

Timely access to appropriate antimicrobials is essential for patient care, antimicrobial stewardship & minimising the risk of resistance - excellent summary of the issues here: amr.solutions/2025/04/07/y... Thanks to @johnhrexmd.bsky.social for highlighting our paper #AMR #AntibioticAccess #AMS 💊

🔔 NEW in the Medical Journal of Australia Shortages of benzathine benzylpenicillin G in Australia highlight the need for new sovereign manufacturing capability ✍️ Rosemary Wyber, Glenn Pearson and Laurens Manning OPEN ACCESS www.mja.com.au/journal/2025...

Fantastic (& FREE) presentation from Assoc Prof Hayley Blackburn on reducing medication waste in hospitals. Pharmacy can lead on this! Medicines are key contributors to the healthcare carbon footprint & cause water pollution adpha.au/event/medsaw... #RxforClimate #OneHealth #AdPhA #AMR #medwaste

#WHO study shows high gonococcal resistance to #tetracycline (92% isolates in 8 countries) #DoxyPEP unlikely to reduce gonorrhoea. Adverse impact to consider: selection of MDR gonococcal strains, impact on other pathogens & commensals doi.org/10.1093/jac/... #AMR #EGASP @bsacandjac.bsky.social

New report scoping data capture in residential aged care facilities aehrc.csiro.au/wp-content/u... No mention of external care providers using different documentation systems for IV meds, a data gap highlighted by Maher et al: doi.org/10.1016/j.ja... #medicines #agedcare #RACF @csiro.bsky.social

The access pathway for unregistered medicines in Australia is used extensively to access antimicrobials, including for life-threatening infections Difficulty accessing appropriate antimicrobials is not only a problem affecting LMICs doi.org/10.1093/jaca... @nadinehillock.bsky.social

On average, 15–16 patients/day require an antibacterial not registered for use in Australia Highlights that new pathways are needed to register antibacterials for otherwise untreatable infections doi.org/10.1093/jaca... @jac-amr.bsky.social @drewabow.bsky.social @peripatetical.bsky.social #AMR

WHO report warns AMR is now a top killer in Africa, surpassing malaria, HIV, and TB, with 1.05M deaths in 2019. Poor drug access, substandard meds, and antibiotic overuse fuel the crisis. #AMR #GlobalHealth #OneHealth#AMR #GlobalHealth #OneHealth reliefweb.int/report/world...

Miscommunication about AMR fuels fear and misinformation. Scare tactics cause inaction, hygiene myths ignore key drivers, and "natural cures" delay treatment. Clear, actionable messaging is key to combatting #AMR effectively. #infectiousdisease #onehealth sciencenigeria.com/experts-high...

Dr Kylie McIntosh Safer Care Victoria providing updates on the Victorian pilot of pharmacist led UTI management, implications on #AMS and the critical need to #upskill #communitypharmacists #antimicrobials2025 #pharmacysymposium #IDsky #AMSsky #UTI

@cindyclau.bsky.social #linezolid does one dose fit all???? Most likely not! Dr Cindy Lau goes through some scenarios - elderly, renal and hepatic impairment, #DDIs - where dose reductions may be warranted to improve patient care (& reduce toxicities) #antimicrobials2025 #IDsky #amssky

Kicking off the #pharmacysymposium We have @michyong.bsky.social highlighting the use of marabivir in tricky #ID populations #CMV and real world use beyond the clinical trials. (With promising clinical effectiveness) #antiviralstewardship #antimicrobials2025

Giske: beware using Cefiderocol discs in MBL strains - many isolates are S by MIC but in ATU (uncertain) on disc, resulting in over-calling of resistance. #antimicrobials2025

Highlighting undocumented off-label topical use of rifampicin during surgery in Australian hospitals, and opportunities for AMS #Antimicrobials2025 #ASA2025 #rifampicin #surgery #AntimicrobialStewardship @edraby.bsky.social #MattRawlins

Advocating for linezolid TDM to improve patient outcomes 😊#Antimicrobials2025 #ASA2025 #linezolid #TDM @lisaparadiso.bsky.social

@iainabbott.bsky.social #antimicrobials2025 Excellent summary slides of current and future oral antimicrobials for #UTIs and what’s lefts in the case of #MDR UTIs #IDSky #AMSsky

Urinary concentrations of antibiotics much more variable bt patients (compared to variability in blood conc). Many variables to consider including fluid intake, variability across a day, other urodynamic factors - Iain Abbott discussing complexity of treating MDR UTIs #Antimicrobials2025 #AMR #UTI

Should we still be thinking of classifying UTIs using a dichotomous definition - complicated vs uncomplicated? Dr Iain Abbott explaining that UTIs are described across more of a spectrum … #Antimicrobials2025 #UTI

Multiple challenges associated with AMR testing of Gm-negative bacteria - may result in over-reporting of resistance rates (e.g cefiderocol) potentially denying patients optimal treatment options, or under-reporting with life-threatening consequences - Prof Christian Giske #Antimicrobials2025 #AMR

Fluoroquinolone resistance in E.coli still lower in Australia compared to most European countries - Jan Bell presenting AGAR data #antimicrobials2025 #ASA2025 #AMR #Ecoli

Surveillance of Gm negative resistance rates in Australia includes all organisms on the WHO list of priority pathogens, & good representation from across Australian states/territories - Jan Bell presenting at #Antimicrobials2025 #ASA2025 #GmNeg

Great line up of speakers on Gram negative bacteria #Antimicrobials2025 #ASA2025 #GramNeg #GmNeg #GramNegative

Prof Gabrielle Haeusler updating us on year in #AMSsky. Highlighting really important piece by the SNAPPY team on age inclusion in clinical trials. pubmed.ncbi.nlm.nih.gov/39158898/ #Antimicrobials2025

Combining NAUSP & NAPS datasets shows that in general restricted antibiotics have lower usage rates and higher appropriateness, but appropriateness of unrestricted antimicrobials should still be targets for AMS - Caroline Chen #Antimicrobials2025 @cazchen.bsky.social #surveillance #AMS

Lipid nanocrystal oral amphotericin … novel technology - targeted release of the drug inside in the cell avoids much of the toxicity - exciting new research (now in phase 3 trials) being discussed by @erinmccreary.bsky.social at #Antimicrobials2025 💊💊 #Antifungals

@erinmccreary.bsky.social presenting on the new antifungal pipeline with novel patient experiences with them #antimicrobials2025 #IDsky #AMSsky #antifungals #mycology

Inappropriate and unregulated use of combination topical products containing antifungals, steroids and sub-therapeutic doses of antibiotics has resulted in spread of resistant strains of dermatophytes across Indian subcontinent - Dr Sarah Kidd #Antimicrobials2025 #AntifungalResistance #AMR